Skip to main content
. 2013 Mar 9;6(1):17–25. doi: 10.4021/gr513w

Table 3. Univariate Comparison of Clinical and Histological Features Between the Two Groups of NAFLD or CHB Patients Divided by Degree of Fibrosis.

NAFLD CHB
Mild fibrosis Advanced fibrosis P value Mild fibrosis Advanced fibrosis P value
Number 40 12 35 33
Age 40 59.0 0.002 37 41 0.390
Gender (Female) 12 (30.0%) 9 (75.0%) 0.006 11 (31.4%) 11 (33.3%) 0.868
BMI (kg/m2) 27.7 28.0 0.983 21.8 23.8 0.052
Obesity (BMI > 25) 29 (72.5%) 10 (83.3%) 0.452 8 (22.9%) 13 (39.4%) 0.143
Diabetes 16 (40.0%) 8 (66.7%) 0.108 2 (5.7) 3 (9.1%) 0.597
Hyperlipidemia 28 (70.0%) 7 (58.3%) 0.454 12 (34.3%) 10 (30.3%) 0.728
Hypertension 24 (60.0%) 8 (66.7%) 0.680 10 (28.6%) 12 (36.4%) 0.496
AST (U/L) 55 73.5 0.487 50 49 0.750
ALT (U/L) 93 81.5 0.307 76 79 0.589
Total bilirubin (mg/dL) 0.6 0.8 0.081 0.8 0.6 0.083
Albumin (g/dL) 4.3 4.0 0.016 4 3.7 0.160
Triglycerides (mg/dL) 156.5 128.0 0.400 82 105 0.393
Total cholesterol (mg/dL) 209 193 0.196 169 178 0.599
Glucose (mg/dL) 96 111 0.424 85 92 0.233
Platelet count (104/µL) 22.8 14.2 < 0.001 18.5 15.2 0.004
Prothrombin time (%) 100 77.5 < 0.001 98.6 86 0.003
Appendectomy 11 (27.5%) 8 (66.7%) 0.014 6 (17.1%) 6 (18.2%) 0.911
Steatosis (grade 0/1/2/3) 0/11/17/12 0/6/6/0 0.036 21/7/6/1 16/14/3/0 0.717